• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishDashboard
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI employees
    Legal
    Terms of usePrivacy policyCookie policy

    SEC Form SC 13G/A filed by Nutanix Inc. (Amendment)

    2/9/23 12:01:00 PM ET
    $NTNX
    Computer Software: Prepackaged Software
    Technology
    Get the next $NTNX alert in real time by email
    SC 13G/A 1 filing.txt SCHEDULE 13G Amendment No.10 NUTANIX INC CLASS A COMMON STOCK Cusip #67059N108 Check the appropriate box to designate the rule pursuant to which this Schedule is filed: [x] Rule 13d-1(b) [ ] Rule 13d-1(c) [ ] Rule 13d-1(d) Cusip #67059N108 Item 1: Reporting Person - FMR LLC Item 2: (a) [ ] (b) [ ] Item 4: Delaware Item 5: 34,588,737 Item 6: 0 Item 7: 34,589,461 Item 8: 0 Item 9: 34,589,461 Item 11: 15.026% Item 12: HC Cusip #67059N108 Item 1: Reporting Person - Abigail P. Johnson Item 2: (a) [ ] (b) [ ] Item 4: United States of America Item 5: 0 Item 6: 0 Item 7: 34,589,461 Item 8: 0 Item 9: 34,589,461 Item 11: 15.026% Item 12: IN 72,872 of the shares of Class A Common Stock of NUTANIX INC reported as being beneficially owned by the reporting persons at December 31, 2022, are included in this Schedule 13G because the Reporting persons are deemed to beneficially own such shares as a result of the direct ownership of 72,872 shares of Class B Common Stock of NUTANIX INC by investment companies advised by Fidelity Management & Research Company LLC an indirect wholly-owned subsidiary of FMR LLC as of such date, which shares of Class B Common Stock are convertible into shares of Class A Common Stock at the election of the holder at an exchange rate of 1:1. Such shares of B Common Stock represent 3.2062% of the outstanding Class B Common Stock. Assuming the conversion of all outstanding shares of Class B Common Stock into Class A Common Stock, the 34,589,461 shares of Class A Common Stock reported as being beneficially owned by the reporting persons in this Schedule 13G would represent 14.8846% of the outstanding Class A Common Stock. Item 1(a). Name of Issuer: NUTANIX INC Item 1(b). Address of Issuer's Principal Executive Offices: 1740 Technology Drive, Suite 150 San Jose, CA 95110 USA Item 2(a). Name of Person Filing: FMR LLC Item 2(b). Address or Principal Business Office or, if None, Residence: 245 Summer Street, Boston, Massachusetts 02210 Item 2(c). Citizenship: Not applicable Item 2(d). Title of Class of Securities: CLASS A COMMON STOCK Item 2(e). CUSIP Number: 67059N108 Item 3. This statement is filed pursuant to Rule 13d-1(b) or 13d-2(b) or (c) and the person filing, FMR LLC, is a parent holding company in accordance with Section 240.13d-1(b)(1)(ii)(G). (Note: See Exhibit A). Item 4. Ownership (a) Amount Beneficially Owned: 34,589,461 (b) Percent of Class: 15.026% (c) Number of shares as to which such person has: (i) sole power to vote or to direct the vote: Please see the responses to Items 5 and 6 on the cover page (ii) shared power to vote or to direct the vote: 0 (iii) sole power to dispose or to direct the disposition of: 34,589,461 (iv) shared power to dispose or to direct the disposition of: 0 72,872 of the shares of Class A Common Stock of NUTANIX INC reported as being beneficially owned by the reporting persons at December 31, 2022, are included in this Schedule 13G because the Reporting persons are deemed to beneficially own such shares as a result of the direct ownership of 72,872 shares of Class B Common Stock of NUTANIX INC by investment companies advised by Fidelity Management & Research Company LLC an indirect wholly-owned subsidiary of FMR LLC as of such date, which shares of Class B Common Stock are convertible into shares of Class A Common Stock at the election of the holder at an exchange rate of 1:1. Such shares of B Common Stock represent 3.2062% of the outstanding Class B Common Stock. Assuming the conversion of all outstanding shares of Class B Common Stock into Class A Common Stock, the 34,589,461 shares of Class A Common Stock reported as being beneficially owned by the reporting persons in this Schedule 13G would represent 14.8846% of the outstanding Class A Common Stock. Item 5. Ownership of Five Percent or Less of a Class. Not applicable. Item 6. Ownership of More than Five Percent on Behalf of Another Person. One or more other persons are known to have the right to receive or the power to direct the receipt of dividends from, or the proceeds from the sale of, the CLASS A COMMON STOCK of NUTANIX INC. The interest of Fidelity Growth Company Commingled Pool, in the CLASS A COMMON STOCK of NUTANIX INC, amounted to 15,574,467 shares or 6.766% of the total outstanding CLASS A COMMON STOCK at December 30, 2022. The interest of Fidelity Growth Company Fund, in the CLASS A COMMON STOCK of NUTANIX INC, amounted to 11,789,433 shares or 5.121% of the total outstanding CLASS A COMMON STOCK at December 30, 2022. Item 7. Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on By the Parent Holding Company. See attached Exhibit A. Item 8. Identification and Classification of Members of the Group. Not applicable. Item 9. Notice of Dissolution of Group. Not applicable. Item 10. Certifications. By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were acquired and are held in the ordinary course of business and were not acquired and are not held for the purpose of or with the effect of changing orinfluencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect. Signature After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct. February 9, 2023 Date /s/ Stephanie J. Brown Signature Stephanie J. Brown Duly authorized under Power of Attorney effective as of January 3, 2023, by and on behalf of FMR LLC and its direct and indirect subsidiaries* * This power of attorney is incorporated herein by reference to Exhibit 24 to the Schedule 13G filed by FMR LLC on January 10, 2023, accession number: 0000315066-23-000003. Exhibit A Pursuant to the instructions in Item 7 of Schedule 13G, the following table lists the identity and Item 3 classification, if applicable, of each relevant entity that beneficially owns shares of the security class being reported on this Schedule 13G. Entity ITEM 3 Classification Fidelity Management & Research Company LLC * IA Fidelity Management Trust Company * BK * Entity beneficially owns 5% or greater of the outstanding shares of the security class being reported on this Schedule 13G. Abigail P. Johnson is a Director, the Chairman and the Chief Executive Officer of FMR LLC. Members of the Johnson family, including Abigail P. Johnson, are the predominant owners, directly or through trusts, of Series B voting common shares of FMR LLC, representing 49% of the voting power of FMR LLC. The Johnson family group and all other Series B shareholders have entered into a shareholders' voting agreement under which all Series B voting common shares will be voted in accordance with the majority vote of Series B voting common shares. Accordingly, through their ownership of voting common shares and the execution of the shareholders' voting agreement, members of the Johnson family may be deemed, under the Investment Company Act of 1940, to form a controlling group with respect to FMR LLC. This filing reflects the securities beneficially owned, or that may be deemed to be beneficially owned, by FMR LLC, certain of its subsidiaries and affiliates, and other companies (collectively, the "FMR Reporters"). This filing does not reflect securities, if any, beneficially owned by certain other companies whose beneficial ownership of securities is disaggregated from that of the FMR Reporters in accordance with Securities and Exchange Commission Release No. 34-39538 (January 12, 1998). RULE 13d-1(k)(1) AGREEMENT The undersigned persons, on February 9, 2023, agree and consent to the joint filing on their behalf of this Schedule 13G in connection with their beneficial ownership of the CLASS A COMMON STOCK of NUTANIX INC at December 30, 2022. FMR LLC By /s/ Stephanie J. Brown Stephanie J. Brown Duly authorized under Power of Attorney effective as of January 3, 2023, by and on behalf of FMR LLC and its direct and indirect subsidiaries* Abigail P. Johnson By /s/ Stephanie J. Brown Stephanie J. Brown Duly authorized under Power of Attorney effective as of January, 26, 2023, by and on behalf of Abigail P. Johnson** * This power of attorney is incorporated herein by reference to Exhibit 24 to the Schedule 13G filed by FMR LLC on January 10, 2023, accession number: 0000315066-23-000003. ** This power of attorney is incorporated herein by reference to Exhibit 24 to the Schedule 13G filed by FMR LLC on January 31, 2023, accession number: 0000315066-23-000038.
    Get the next $NTNX alert in real time by email

    Chat with this insight

    Save time and jump to the most important pieces.

    Recent Analyst Ratings for
    $NTNX

    DatePrice TargetRatingAnalyst
    5/20/2025Outperform → Mkt Perform
    Raymond James
    2/27/2025$77.00 → $97.00Market Perform → Outperform
    Northland Capital
    12/12/2024$81.00Buy
    UBS
    11/13/2024$80.00Outperform
    Oppenheimer
    10/28/2024$71.00 → $72.00Equal-Weight → Overweight
    Morgan Stanley
    5/30/2024$71.00Outperform → Market Perform
    Northland Capital
    5/8/2024$72.00Mkt Perform → Outperform
    Raymond James
    1/17/2024Mkt Perform → Outperform
    William Blair
    More analyst ratings

    $NTNX
    SEC Filings

    See more
    • Nutanix Inc. filed SEC Form 8-K: Leadership Update

      8-K - Nutanix, Inc. (0001618732) (Filer)

      6/16/25 5:18:31 PM ET
      $NTNX
      Computer Software: Prepackaged Software
      Technology
    • SEC Form 10-Q filed by Nutanix Inc.

      10-Q - Nutanix, Inc. (0001618732) (Filer)

      6/3/25 4:08:53 PM ET
      $NTNX
      Computer Software: Prepackaged Software
      Technology
    • SEC Form 144 filed by Nutanix Inc.

      144 - Nutanix, Inc. (0001618732) (Subject)

      6/2/25 2:55:15 PM ET
      $NTNX
      Computer Software: Prepackaged Software
      Technology

    $NTNX
    Press Releases

    Fastest customizable press release news feed in the world

    See more
    • Nutanix Study Finds Public Sector Embraces Generative AI, but Faces Security, Skills, and Infrastructure Gaps

      SAN JOSE, Calif., June 17, 2025 (GLOBE NEWSWIRE) -- Nutanix (NASDAQ:NTNX), a leader in hybrid multicloud computing, announced the findings of its seventh annual global Public Sector Enterprise Cloud Index (ECI) survey and research report, which measures enterprise progress with cloud adoption in the industry. The research showed that 83% of public sector organizations have a GenAI strategy in place, with 54% actively implementing, and 29% preparing for implementation. As public sector organizations ramp up GenAI adoption, 76% of IT decision-makers say their current infrastructure needs moderate to significant improvement to support modern, cloud native applications at scale. This year's

      6/17/25 9:00:00 AM ET
      $NTNX
      Computer Software: Prepackaged Software
      Technology
    • Nutanix to Host Tech Talk on Cloud Native Capabilities

      SAN JOSE, Calif., June 09, 2025 (GLOBE NEWSWIRE) -- Nutanix, Inc. (NASDAQ:NTNX), a leader in hybrid multicloud computing, today announced that it will host a webinar to discuss the cloud native capabilities of the Nutanix Cloud Platform, including Nutanix Kubernetes Platform, Nutanix Data Services for Kubernetes and Nutanix Enterprise AI. Speakers will include:Thomas Cornely, SVP, Product ManagementDan Ciruli, Sr. Director, Product Management No financial information will be discussed during the event. Date and Time:Friday, June 13, 20258:00 a.m. PDT; 11:00 a.m. EDT To register for the webinar, please access the link here. A live webcast and replay of the presentation will also be acc

      6/9/25 8:00:00 AM ET
      $NTNX
      Computer Software: Prepackaged Software
      Technology
    • Nutanix Reports Third Quarter Fiscal 2025 Financial Results

        Delivers Outperformance Across All Guided Metrics Reports 18% YoY ARR Growth and Strong Free Cash Flow SAN JOSE, Calif., May 28, 2025 (GLOBE NEWSWIRE) -- Nutanix, Inc. (NASDAQ:NTNX), a leader in hybrid multicloud computing, today announced financial results for its third quarter ended April 30, 2025. "We delivered solid third quarter results, above the high end of our guided ranges, driven by the strength of the Nutanix Cloud Platform and demand from businesses looking for a trusted long-term partner," said Rajiv Ramaswami, President and CEO of Nutanix. "Our recent announcements around support for external storage, modern applications, and generative AI reflect our continued focus on

      5/28/25 4:01:00 PM ET
      $NTNX
      Computer Software: Prepackaged Software
      Technology

    $NTNX
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    See more
    • Nutanix downgraded by Raymond James

      Raymond James downgraded Nutanix from Outperform to Mkt Perform

      5/20/25 8:09:15 AM ET
      $NTNX
      Computer Software: Prepackaged Software
      Technology
    • Nutanix upgraded by Northland Capital with a new price target

      Northland Capital upgraded Nutanix from Market Perform to Outperform and set a new price target of $97.00 from $77.00 previously

      2/27/25 7:00:01 AM ET
      $NTNX
      Computer Software: Prepackaged Software
      Technology
    • UBS initiated coverage on Nutanix with a new price target

      UBS initiated coverage of Nutanix with a rating of Buy and set a new price target of $81.00

      12/12/24 8:44:04 AM ET
      $NTNX
      Computer Software: Prepackaged Software
      Technology